Guo D - Search Results

1

Clinicopathological and molecular genetic analysis of 13 cases of primary retroperitoneal Ewing sarcoma.

Wei X, Cheng M, Wang L, Teng X, Guo D, Xin X, Chen G, Li S, Li F. Wei X, et al. Among authors: guo d. Ann Diagn Pathol. 2024 Oct;72:152321. doi: 10.1016/j.anndiagpath.2024.152321. Epub 2024 May 6. Ann Diagn Pathol. 2024. PMID: 38759563

2

Individual surveillance by competing risk model for patients with hepatocellular carcinoma occurrence in all-cause cirrhosis.

Wang Q, Guo D, Gao W, Yuan C, Li J, Zhang Y, He N, Zhao P, Zheng J, Zhang Y. Wang Q, et al. Among authors: guo d. J Cancer Res Clin Oncol. 2023 Nov;149(14):13403-13416. doi: 10.1007/s00432-023-04911-y. Epub 2023 Jul 26. J Cancer Res Clin Oncol. 2023. PMID: 37495731 Free PMC article.

3

The hepatocellular carcinoma risk in patients with HBV-related cirrhosis: a competing risk nomogram based on a 4-year retrospective cohort study.

Guo D, Li J, Zhao P, Mei T, Li K, Zhang Y. Guo D, et al. Front Oncol. 2024 May 16;14:1398968. doi: 10.3389/fonc.2024.1398968. eCollection 2024. Front Oncol. 2024. PMID: 38817899 Free PMC article.

4

Bone marrow suppression or active proliferation? An analysis of neutropenia after pegylated interferon treatment of patients with chronic hepatitis C.

Liu YL, Du XF, Chen XY, Ma LN, Guo DD, Lu JF, Cao ZH, Zhang YH. Liu YL, et al. Scand J Infect Dis. 2013 Dec;45(12):939-43. doi: 10.3109/00365548.2013.835067. Epub 2013 Oct 3. Scand J Infect Dis. 2013. PMID: 24090457

5

Deletion of Smad4 reduces hepatic inflammation and fibrogenesis during nonalcoholic steatohepatitis progression.

Qin G, Wang GZ, Guo DD, Bai RX, Wang M, Du SY. Qin G, et al. J Dig Dis. 2018 May;19(5):301-313. doi: 10.1111/1751-2980.12599. Epub 2018 Jun 6. J Dig Dis. 2018. PMID: 29696816

6

The effect of cytokine profiles on the viral response to re-treatment in antiviral-experienced patients with chronic hepatitis C virus infection.

Zhang Y, Guo D, Zhao Y, Chen X, Ma L, Jin Y, Yan H, Wu H, Wei L, Dong T, Chen X. Zhang Y, et al. Among authors: guo d. Antiviral Res. 2011 Nov;92(2):247-54. doi: 10.1016/j.antiviral.2011.08.009. Epub 2011 Aug 26. Antiviral Res. 2011. PMID: 21889543

7

Dynamic Changes of Cytokine Profiles and Their Correlation With Tumor Recurrence Following Thermal Ablation in Hepatocellular Carcinoma.

Guo D, Qin L, Sun J, Li K, Zang C, Wang Q, Qiao W, Liu B, Zhao Y, Zhang Y. Guo D, et al. Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231190644. doi: 10.1177/15330338231190644. Technol Cancer Res Treat. 2023. PMID: 37525880 Free PMC article.

8

The methylation signature of hepatocellular carcinoma trajectory based on pseudotime and chronological time for predicting precancerous patients.

Li K, Zang C, Zhao Y, Guo D, Shi W, Mei T, Li A, Zhang Y. Li K, et al. Among authors: guo d. Oncologist. 2024 Nov 26:oyae292. doi: 10.1093/oncolo/oyae292. Online ahead of print. Oncologist. 2024. PMID: 39589232 Free article.

9

METTL4 and METTL5 as biomarkers for recurrence-free survival in hepatocellular carcinoma patients.

Zhao J, Sun R, Zhi L, Guo D, Ling S, Liang X, Li J, Jia C. Zhao J, et al. Among authors: guo d. Future Oncol. 2024 Dec 20:1-10. doi: 10.1080/14796694.2024.2442296. Online ahead of print. Future Oncol. 2024. PMID: 39706798

10

Constructing industrial lignin into robust and multifunctional superhydrophobic coating for effective anti-icing.

Wang L, Guo Z, Guo D, Li J, Janaswamy S, Yang G, Ji X, Lyu G. Wang L, et al. Among authors: guo d. Int J Biol Macromol. 2024 Dec 17;289:138891. doi: 10.1016/j.ijbiomac.2024.138891. Online ahead of print. Int J Biol Macromol. 2024. PMID: 39701261

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,825 results

Search Page

Filters